BriaCell Therapeutics Corp. Stock Analysis & AI Score
BriaCell Therapeutics Corp. (BCTX) has an ST Score of 45.0 (C+), driven by its Financial Strength (B+) and held back by its Profitability (F). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
BriaCell Therapeutics Corp. (BCTX) has an ST Score of 45.0 (C+), driven by its Financial Strength (B+) and held back by its Profitability (F). Analysts rate it Buy.
- Strongest
- Financial StrengthB+
- Weakest
- ProfitabilityF
All factor grades
- Financial StrengthB+
- MomentumB
- GrowthB
- ValuationB-
- ProfitabilityF
- Piotroski2/9
Contact
BCTX stock: frequently asked questions
What is BCTX's ST Score?
BriaCell Therapeutics Corp. (BCTX) has an ST Score of 45.0 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is BCTX a buy, hold, or sell?
Analysts rate BCTX a Buy. Our ST Score grades it C+ (45.0/100). The ST Score is a data-driven signal, not a recommendation.
What are BCTX's factor grades?
Valuation B-, Profitability F, Financial Strength B+, Momentum B, Growth B.
What is BCTX's valuation grade?
BriaCell Therapeutics Corp. (BCTX) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is BCTX's growth grade?
BriaCell Therapeutics Corp. (BCTX) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is BCTX's profitability grade?
BriaCell Therapeutics Corp. (BCTX) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is BCTX's financial strength grade?
BriaCell Therapeutics Corp. (BCTX) earns a financial strength grade of B+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is BCTX's Piotroski score?
BriaCell Therapeutics Corp. (BCTX) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.